These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38618065)

  • 21. Willingness to pay to sustain and expand National Health Insurance services in Taiwan.
    Lang HC; Lai MS
    BMC Health Serv Res; 2008 Dec; 8():261. PubMed ID: 19091093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valuing healthcare under Taiwan's national health insurance.
    Chen WY; Lee JL; Liang YW; Hung CT; Lin YH
    Expert Rev Pharmacoecon Outcomes Res; 2008 Oct; 8(5):501-8. PubMed ID: 20528335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of medical cost controls implemented by Taiwan's national health insurance program on doctor-patient relationships.
    Chiu JL
    Int J Health Plann Manage; 2015; 30(1):E31-41. PubMed ID: 24890571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of Taiwan's health care system.
    Rachel Lu JF; Chiang TL
    Health Econ Policy Law; 2011 Jan; 6(1):85-107. PubMed ID: 20199715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Building a national electronic medical record exchange system - experiences in Taiwan.
    Li YC; Yen JC; Chiu WT; Jian WS; Syed-Abdul S; Hsu MH
    Comput Methods Programs Biomed; 2015 Aug; 121(1):14-20. PubMed ID: 26001420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term care insurance in taiwan: theory and challenges].
    Lee JL; Lung CH; Liu LF
    Hu Li Za Zhi; 2010 Aug; 57(4):11-6. PubMed ID: 20661851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of pemigatinib as a second-line treatment for advanced intrahepatic cholangiocarcinoma with fibroblast growth factor receptor 2 fusions in Taiwan: from the evidence of the phase II trial and the perspective of Taiwan's National Health Insurance Administration.
    Chen ZR; Chueh CH; Chiang NJ; Tsai YW
    Cost Eff Resour Alloc; 2023 Sep; 21(1):61. PubMed ID: 37697368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The demand for healthcare under Taiwan's national health insurance: a count data model approach.
    Lin YH; Chen WY
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):13-22. PubMed ID: 19371173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Out-of-pocket payment for medical care under Taiwan's National Health Insurance system.
    Chi C; Lee JL; Tsai SL; Chen WY
    Health Econ; 2008 Aug; 17(8):961-75. PubMed ID: 18004793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The new co-payment policy under Taiwan's National Health Insurance: welfare gain or welfare loss?
    Chen WY; Bernell S; McMullen BS
    Expert Rev Pharmacoecon Outcomes Res; 2008 Apr; 8(2):141-9. PubMed ID: 20528403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergency Medical Services in Taiwan: Past, Present, and Future.
    Huan TL; Lee AF; Chien YC; Lin CH; Lee BC; Chung YT; Cheng HH; Chen CY; Lin HY; Sun JT; Hsieh MJ; Ma MH; Chiang WC
    J Acute Med; 2023 Sep; 13(3):91-103. PubMed ID: 37841822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The utilization of radionuclide myocardial perfusion imaging and cardiac catheterization under Taiwan's universal health insurance program.
    Lin MC; Yen RF; Chen HY; Muo CH; Wang HE; Chen CL; Kao CH
    Int J Cardiovasc Imaging; 2013 Jun; 29(5):1039-42. PubMed ID: 23515948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taiwan's Public Health National Laboratory System: Success in Influenza Diagnosis and Surveillance.
    Yang JR; Teng HJ; Liu MT; Li SY
    Health Secur; 2017; 15(2):154-164. PubMed ID: 28418742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring health care efficiency with a tripartite configuration under the "National" Health Insurance system.
    Kreng VB; Yang SW; Lin CH
    Chin Med J (Engl); 2014; 127(9):1633-9. PubMed ID: 24791866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urban-rural disparity of preventive healthcare utilisation among children under the universal health insurance coverage in Taiwan: a national birth cohort analysis.
    Lu CL; Hsu YH; Su WL; Damayanti NA; Chen CW; Lin YJ; Tsai KS; Li CY
    Public Health; 2020 May; 182():102-109. PubMed ID: 32247105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social capital and preventive care use among the elderly under Taiwan's National Health Insurance.
    Peng YI; Lin TF
    Arch Gerontol Geriatr; 2018; 75():28-36. PubMed ID: 29175374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis in chemotherapy-induced febrile neutropenia among breast cancer and Non-Hodgkin's lymphoma patients under Taiwan's national health insurance system.
    Wen TJ; Wen YW; Chien CR; Chiang SC; Hsu WW; Shen LJ; Hsiao FY
    J Eval Clin Pract; 2017 Apr; 23(2):288-293. PubMed ID: 27491287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A real-world observational study of drug utilization and clinical outcomes of direct-acting antivirals and interferon therapy for hepatitis C treatment in Taiwan.
    Chen JH; Wu PN; Huang SC; Hsu PJ; Hsu JC
    Curr Med Res Opin; 2021 Feb; 37(2):245-252. PubMed ID: 33251875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of integrated health care on elderly population: A systematic review of Taiwan's experience.
    Chen TL; Feng YH; Kao SL; Lu JW; Loh CH
    Arch Gerontol Geriatr; 2022; 102():104746. PubMed ID: 35691276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of morbidity trajectories on identifying high-cost cases: using Taiwan's National Health Insurance as an example.
    Chang HY
    J Public Health (Oxf); 2014 Jun; 36(2):300-7. PubMed ID: 23740662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.